TABLE 1.
Pre-existing conditions* | Yes | (%) | No | (%) | Unknown | (%) | NA | (%) |
---|---|---|---|---|---|---|---|---|
Immunodeficiency | 26 | (49%) | 6 | (11%) | 0 | (0%) | 21 | (40%) |
Malignancy | 24 | (45%) | 28 | (53%) | 0 | (0%) | 1 | (2%) |
Hematologic disease | 10 | (19%) | 14 | (26%) | 0 | (0%) | 29 | (55%) |
Cardiac disease | 11 | (21%) | 40 | (75%) | 0 | (0%) | 2 | (4%) |
Chronic lung disease | 10 | (19%) | 40 | (75%) | 0 | (0%) | 3 | (6%) |
Chronic liver disease | 5 | (9%) | 39 | (74%) | 0 | (0%) | 9 | (17%) |
Kidney disease | 5 | (9%) | 47 | (89%) | 0 | (0%) | 1 | (2%) |
Diabetes | 1 | (2%) | 52 | (98%) | 0 | (0%) | 0 | (0%) |
Other pre-existing conditions† | 37 | (70%) | 0 | (0%) | 0 | (0%) | 16 | (30%) |
Symptoms at admission | ||||||||
Upper respiratory tract symptoms | 31 | (58%) | 21 | (40%) | 1 | (2%) | 0 | (0%) |
Fever | 30 | (57%) | 21 | (40%) | 2 | (4%) | 0 | (0%) |
Gastrointestinal symptoms | 12 | (23%) | 41 | (77%) | 0 | (0%) | 0 | (0%) |
Lower respiratory tract symptoms | 12 | (23%) | 41 | (77%) | 0 | (0%) | 0 | (0%) |
Neurologic symptoms | 7 | (13%) | 46 | (87%) | 0 | (0%) | 0 | (0%) |
Unknown, information was unknown to the study center; NA, no information provided by the study center.
Some patients had >1 pre-existing condition.
†Other pre-existing conditions comprised a variety of medical conditions other than those listed previously, including chromosomal abnormalities and prematurity.